Overview

Ceftriaxone and Jaundice in Neonates

Status:
Completed

Trial end date:
2019-08-31

Target enrollment:

Participant gender:

Summary

Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.

Details

Lead Sponsor:

sanjiv amin
University of Rochester

Treatments:

Ceftriaxone